326 related articles for article (PubMed ID: 26725703)
1. The Epidemiology and Genetics of Uterine Leiomyoma.
Styer AK; Rueda BR
Best Pract Res Clin Obstet Gynaecol; 2016 Jul; 34():3-12. PubMed ID: 26725703
[TBL] [Abstract][Full Text] [Related]
2. Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.
Commandeur AE; Styer AK; Teixeira JM
Hum Reprod Update; 2015; 21(5):593-615. PubMed ID: 26141720
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs in the development and pathobiology of uterine leiomyomata: does evidence support future strategies for clinical intervention?
Karmon AE; Cardozo ER; Rueda BR; Styer AK
Hum Reprod Update; 2014; 20(5):670-87. PubMed ID: 24706045
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA 21a-5p overexpression impacts mediators of extracellular matrix formation in uterine leiomyoma.
Cardozo ER; Foster R; Karmon AE; Lee AE; Gatune LW; Rueda BR; Styer AK
Reprod Biol Endocrinol; 2018 May; 16(1):46. PubMed ID: 29747655
[TBL] [Abstract][Full Text] [Related]
5. Epigenomic and enhancer dysregulation in uterine leiomyomas.
Mlodawska OW; Saini P; Parker JB; Wei JJ; Bulun SE; Simon MA; Chakravarti D
Hum Reprod Update; 2022 Jun; 28(4):518-547. PubMed ID: 35199155
[TBL] [Abstract][Full Text] [Related]
6. The Mediator Complex Subunit 12 (MED-12) Gene and Uterine Fibroids: a Systematic Review.
Amendola ILS; Spann M; Segars J; Singh B
Reprod Sci; 2024 Feb; 31(2):291-308. PubMed ID: 37516697
[TBL] [Abstract][Full Text] [Related]
7. Loss of the repressor REST in uterine fibroids promotes aberrant G protein-coupled receptor 10 expression and activates mammalian target of rapamycin pathway.
Varghese BV; Koohestani F; McWilliams M; Colvin A; Gunewardena S; Kinsey WH; Nowak RA; Nothnick WB; Chennathukuzhi VM
Proc Natl Acad Sci U S A; 2013 Feb; 110(6):2187-92. PubMed ID: 23284171
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of Uterine Fibroids: From Menarche to Menopause.
Wise LA; Laughlin-Tommaso SK
Clin Obstet Gynecol; 2016 Mar; 59(1):2-24. PubMed ID: 26744813
[TBL] [Abstract][Full Text] [Related]
9. Proteomic Analysis Identifies Tenascin-C Expression Is Upregulated in Uterine Fibroids.
Jamaluddin MFB; Nagendra PB; Nahar P; Oldmeadow C; Tanwar PS
Reprod Sci; 2019 Apr; 26(4):476-486. PubMed ID: 29730954
[TBL] [Abstract][Full Text] [Related]
10. Genetic Mechanisms Driving Uterine Leiomyoma Pathobiology, Epidemiology, and Treatment.
Ramaiyer MS; Saad E; Kurt I; Borahay MA
Genes (Basel); 2024 Apr; 15(5):. PubMed ID: 38790186
[TBL] [Abstract][Full Text] [Related]
11. MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas.
Mäkinen N; Mehine M; Tolvanen J; Kaasinen E; Li Y; Lehtonen HJ; Gentile M; Yan J; Enge M; Taipale M; Aavikko M; Katainen R; Virolainen E; Böhling T; Koski TA; Launonen V; Sjöberg J; Taipale J; Vahteristo P; Aaltonen LA
Science; 2011 Oct; 334(6053):252-5. PubMed ID: 21868628
[TBL] [Abstract][Full Text] [Related]
12. Early-life exposures and early-onset uterine leiomyomata in black women in the Sister Study.
D'Aloisio AA; Baird DD; DeRoo LA; Sandler DP
Environ Health Perspect; 2012 Mar; 120(3):406-12. PubMed ID: 22049383
[TBL] [Abstract][Full Text] [Related]
13. Altered chromatin landscape and enhancer engagement underlie transcriptional dysregulation in MED12 mutant uterine leiomyomas.
Moyo MB; Parker JB; Chakravarti D
Nat Commun; 2020 Feb; 11(1):1019. PubMed ID: 32094355
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology and Risk Factors of Uterine Fibroids.
Pavone D; Clemenza S; Sorbi F; Fambrini M; Petraglia F
Best Pract Res Clin Obstet Gynaecol; 2018 Jan; 46():3-11. PubMed ID: 29054502
[TBL] [Abstract][Full Text] [Related]
15. [Leiomyomas of the uterine body: Molecular-genetical aspects of formation and development].
Dvorská D; Višňovský J; Braný D; Danko J
Ceska Gynekol; 2016 Jan; 81(1):48-52. PubMed ID: 26982065
[TBL] [Abstract][Full Text] [Related]
16. Association of age at menarche with increasing number of fibroids in a cohort of women who underwent standardized ultrasound assessment.
Velez Edwards DR; Baird DD; Hartmann KE
Am J Epidemiol; 2013 Aug; 178(3):426-33. PubMed ID: 23817917
[TBL] [Abstract][Full Text] [Related]
17. The Mechanism and Function of Epigenetics in Uterine Leiomyoma Development.
Yang Q; Mas A; Diamond MP; Al-Hendy A
Reprod Sci; 2016 Feb; 23(2):163-75. PubMed ID: 25922306
[TBL] [Abstract][Full Text] [Related]
18. Novel MED12 gene somatic mutations in women from the Southern United States with symptomatic uterine fibroids.
Halder SK; Laknaur A; Miller J; Layman LC; Diamond M; Al-Hendy A
Mol Genet Genomics; 2015 Apr; 290(2):505-11. PubMed ID: 25325994
[TBL] [Abstract][Full Text] [Related]
19. Proteomic Profiling of Human Uterine Fibroids Reveals Upregulation of the Extracellular Matrix Protein Periostin.
Jamaluddin MFB; Ko YA; Kumar M; Brown Y; Bajwa P; Nagendra PB; Skerrett-Byrne DA; Hondermarck H; Baker MA; Dun MD; Scott RJ; Nahar P; Tanwar PS
Endocrinology; 2018 Feb; 159(2):1106-1118. PubMed ID: 29244110
[TBL] [Abstract][Full Text] [Related]
20. MED12 mutations in uterine fibroids--their relationship to cytogenetic subgroups.
Markowski DN; Bartnitzke S; Löning T; Drieschner N; Helmke BM; Bullerdiek J
Int J Cancer; 2012 Oct; 131(7):1528-36. PubMed ID: 22223266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
